Literature DB >> 33755853

Negative pressure-assisted endoscopic pilonidal sinus treatment.

P Giordano1, E Schembari2, K Keshishian2, C A Leo2,3.   

Abstract

BACKGROUND: Endoscopic pilonidal sinus treatment (EPSiT) is a novel minimally invasive option for the treatment of pilonidal sinus disease (PSD). To optimise the postoperative wound management after EPSiT, an ultraportable negative pressure wound therapy (NPWT) device was used. The aim of this study was to assess the clinical outcomes of negative pressure-assisted (NPA) EPSiT.
METHODS: All patients with PSD treated by EPSIT from November 2017 to October 2019 were managed postoperatively with a commercially available NPTW dressing applied to the wound. All patients were prospectively entered into a dedicated database. Primary outcome measures were healing rate and return to normal activities. Secondary outcomes were postoperative complications and patient satisfaction.
RESULTS: Thirteen male patients underwent NPA EPSiT (mean age 27.8 years, range 16-52 years). Two patients had previous surgery for PSD. The mean follow-up was 14 months (range 4-28 months). In two patients, only partial healing of the tract was achieved. One of these required a further successful NPA EPSiT, while the other one refused any other treatment because of the lack of symptoms. Eight patients were very satisfied and 5 were satisfied with this treatment.
CONCLUSIONS: NPA EPSiT is a simple method for improving postoperative wound management, facilitating a quicker recovery and possibly improving overall patient satisfaction.

Entities:  

Keywords:  EPSiT; Minimally invasive treatment; NPWT; Pilonidal disease; Pilonidal sinus

Year:  2021        PMID: 33755853     DOI: 10.1007/s10151-021-02431-w

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  8 in total

1.  Endoscopic pilonidal sinus treatment (EPSiT) in recurrent pilonidal disease: a prospective international multicenter study.

Authors:  Piercarlo Meinero; Marco La Torre; Giorgio Lisi; Alessandro Stazi; Antonella Carbone; Luca Regusci; Fabrizio Fasolini
Journal:  Int J Colorectal Dis       Date:  2019-02-04       Impact factor: 2.571

2.  Long-term results of endoscopic pilonidal sinus treatment vs Limberg flap for treatment of difficult cases of complicated pilonidal disease: a prospective, nonrandomized study.

Authors:  M Romaniszyn; J S Swirta; P J Walega
Journal:  Colorectal Dis       Date:  2019-10-06       Impact factor: 3.788

3.  Pilonidal disease: origin from follicles of hairs and results of follicle removal as treatment.

Authors:  J Bascom
Journal:  Surgery       Date:  1980-05       Impact factor: 3.982

4.  Outcomes of minimally invasive endoscopic pilonidal sinus surgery.

Authors:  Jacques Eastment; Kellee Slater
Journal:  Asian J Endosc Surg       Date:  2019-08-15

Review 5.  The Management of Pilonidal Sinus.

Authors:  Igors Iesalnieks; Andreas Ommer
Journal:  Dtsch Arztebl Int       Date:  2019-01-07       Impact factor: 5.594

6.  Endoscopic pilonidal sinus treatment in the Asian population.

Authors:  Clement L K Chia; Vivyan W Y Tay; Surendra K Mantoo
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2015-06       Impact factor: 1.719

7.  Endoscopic pilonidal sinus treatment (E.P.Si.T.).

Authors:  P Meinero; L Mori; G Gasloli
Journal:  Tech Coloproctol       Date:  2013-05-17       Impact factor: 3.781

8.  Endoscopic pilonidal sinus treatment: a prospective multicentre trial.

Authors:  P Meinero; A Stazi; A Carbone; F Fasolini; L Regusci; M La Torre
Journal:  Colorectal Dis       Date:  2016-05       Impact factor: 3.788

  8 in total
  1 in total

1.  Validation of a Manual Negative Pressure Wound Therapy Device (PragmaVAC) for Acute and Chronic Wounds: A Prospective, Randomized, Controlled Trial.

Authors:  Mahmoud Hariri; Bakry Maaz; Measser Netfagi; Jude Alawa; Ahmad Sattouf; Hussam Alden Dubies; Jehad Alahmad; Muhammet Fuat Seyitisa; Amandine Godier-Furnemont; Abedalkarem Ghali; Ahmad Ghandour; Zohair Abdullah; Munther Alsaleh; Ibrahim Almousa; Waiel Habib; Hisham Alshaer
Journal:  World J Surg       Date:  2022-09-29       Impact factor: 3.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.